Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Accumulated Depreciation (2019 - 2020)

Historic Accumulated Depreciation for Pliant Therapeutics (PLRX) over the last 2 years, with Q4 2020 value amounting to $3.5 million.

  • Pliant Therapeutics' Accumulated Depreciation rose 5941.5% to $3.5 million in Q4 2020 from the same period last year, while for Dec 2020 it was $3.5 million, marking a year-over-year increase of 5941.5%. This contributed to the annual value of $3.5 million for FY2020, which is 5941.5% up from last year.
  • Per Pliant Therapeutics' latest filing, its Accumulated Depreciation stood at $3.5 million for Q4 2020, which was up 5941.5% from $3.2 million recorded in Q3 2020.
  • Pliant Therapeutics' Accumulated Depreciation's 5-year high stood at $3.5 million during Q4 2020, with a 5-year trough of $2.2 million in Q4 2019.